Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia

Overview of attention for article published in Frontiers in oncology, February 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 3 X users

patent: 1 patent

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,583 followers.

Reviewing the efficacy of emvododstat in acute myeloid leukemia is the topic in this top article from @FrontOncology: https://t.co/4oE688AxsP. Check out the full AML feed here: https://t.co/GGrp4Os4P0. #oncology #leukemia

28 Feb 2022

Reply Repost Favourite

New article: Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia https://t.co/9MyHArRreL #AML #leusm #hematology https://t.co/C6X1kvkT9W

28 Feb 2022

Reply Repost Favourite

New research: Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia: Blocking the pyrimidine nucleotide de novo synthesis pathway by inhibiting dihydroorotate dehydrogenase… https://t.co/

09 Feb 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.